# Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1543 in Healthy Adult Volunteers

> **NCT05954247** · PHASE1 · UNKNOWN · sponsor: **Daewoong Pharmaceutical Co. LTD.** · enrollment: 24 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** DWJ1543
- **DRUG:** DWC202216

## Key facts

- **NCT ID:** NCT05954247
- **Lead sponsor:** Daewoong Pharmaceutical Co. LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08-01
- **Primary completion:** 2023-12-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2023-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05954247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05954247, "Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1543 in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT05954247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*